Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
alpha-synuclein
biologic markers
gene
genetic neurologic disorders
MRI, functional
MRS
neurologic disease, diagnoses of
neuropathology, brain
neuropathy
Parkinson disease
Parkinson disease, classification
Parkinson disease, etiology of
Parkinson disease, heterogeneity of
Parkinson disease, pathogenesis of
Parkinson disease, subtypes
skin, biopsy
synucleinopathy
Showing articles 850 to 900 of 1691 << Previous Next >>

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Stroke in Young Black Patients:Risk Factors, Subtypes, & Prognosis
Stroke 26:1995-1998, Qureshi,A.I.,et al, 1995

Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995

Variability of Vascular Territory in Stroke:Pitfalls and Failure of Stroke Pattern Interpretation
Stroke 26:942-945, Lang,E.W.,et al, 1995

Ischemic Stroke in Young Adults
Arch Neurol 52:491-495, Adams,H.P.,et al, 1995

Prevalence and Outcome of Symptomatic Carotid Lesions in Young Adults
BMJ 310:1363-1366, Carolei,A.,et al, 1995

Hemiballismus:CT and MR Findings
J Comput Assist Tomogr 19:537-540, Provenzale,J.M.&Glass,J.P., 1995

Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995

Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995

Effect of GPi Pallidotomy on Motor Function in Parkinson's Disease
Lancet 346:1383-1387, Lozano,A.M.,et al, 1995

Clinical and[18F]dopa PET Findings in Early Parkinson's Disease
JNNP 59:597-600, Morrish,P.K.,et al, 1995

Generalized Mitochondrial Dysfunction in Parkinson's Disease Detected by Magnetic Resonance Spectroscopy of Muscle
Neurol 45:2097-2099, Penn,A.M.W.,et al, 1995

Decreased SPECT[123I]B-CIT Striatal Uptake Correlates with Symptom Severity in Parkinson's Disease
Ann Neurol 38:589-598, Seibyl,J.P.,et al, 1995

Psychogenic Movement Disorders:Frequency, Clinical Profile and Characteristics
JNNP 59:406-412, Factor,S.A.,et al, 1995

Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995

Interrater Reliability of an Etiologic Classification of Ischemic Stroke
Stroke 26:46-51, Johnson,C.J.,et al, 1995

Comparative Study of Selegiline Plus L-Dopa-Carbidopa VS L-Dopa-Carbidopa Alone in Trtm of Parkinson's Disease
Ann Neurol 37:95-98, Brannan,T.&Yahr,M.D., 1995

Clinicopathological Study of 35 Cases of Multiple System Atrophy
JNNP 58:160-166, Wenning,G.K.,et al, 1995

Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) from Parkinson's Disease
Arch Neurol 52:294-298, Colosimo,C.,et al, 1995

Different of Multi Syst Atrophy from Idiopathic Parkinson's Disease Using Proton MR Spectroscopy
Ann Neurol 37:204-210, Davie,C.A.,et al, 1995

Effect on Parkinsonian Signs and Symptoms of Bilateral Subthalamic Nucleus Stimulation
Lancet 345:91-95, Limousin,P.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995

Encephalopathy with Parkinsonian Features in Children Following Bone Marrow Transplantations and High-Dose Amphotericin B
Ann Neurol 37:810-814, Mott,S.H.,et al, 1995

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Kindreds of Dominantly Inherited Parkinson's Disease:Keys to the Riddle
Ann Neurol 38:355-356, Duvoisin,R.C.&Golbe,L.I., 1995

A Greek-American Kindred with Autosomal Dominant, Levodopa-Responsive Parkinsonism and Anticipation
Ann Neurol 38:373-378, 3551995., Markopoulou,K.,et al, 1995

Cigarette Smoking and Protection from Parkinson's Disease:False Association or Etiologic Clue?
Neurol 45:1041-1051, Morens,D.M.,et al, 1995

Multiple System Atrophy presenting as Parkinsonism:Clinical Features and Diagnostic Criteria
JNNP 59:144-151, Albanese,A.,et al, 1995

Occurrence of Different Cancers in Patients with Parkinson's Disease
BMJ 310:1500-1501, Moller,H.,et al, 1995

Neuropath Evid of Graft Survival & Striatal Reinnerva after Transpl of Fetal Mesencephalic Tissue in Parkinson's Dis
NEJM 332:1118-1124, 11631995., Kordower,J.H.,et al, 1995

Bilateral Fetal Nigral Transplantation Into the Postcommissural Putamen in Parkinson's Disease
Ann Neurol 38:379-388, Freemen,T.B.,et al, 1995

Stereotactic Ventral Pallidotomy for Parkinson's Disease
Neurol 45:753-761, Dogali,M.,et al, 1995

Electroconvulsive Therapy for the Physical Signs of Parkinson's Disease Without Depressive Disorder
JNNP 58:641-642, Pridmore,S.,et al, 1995

Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995

Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Extrapyramidal Symptoms in a BMT Recipient with Hyperintense Basal Ganglia and Elevated Manganese
Bone Marrow Transplantation 15:989-992, Fredstrom,S.,et al, 1995

Disabling Parkinsonism Due to Lithium: A Case Report
J Geriatr Psychiatry Neurol 8:118-119, Holroyd,S. & Smith,D., 1995

Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994

An Algorithm for the Management of Parkinson's Disease
Neurol 44:S1-S52, Koller,W.C.,et al, 1994

Increased Risk of Parkinson's Disease in Parents and Siblings of Patients
Ann Neurol 36:659-661, Payami,H.,et al, 1994

Assessment of Fetal Tissue Transplantation in Parkinson's Disease:Does PET Play a Role
Neurol 44:1777-1780, Martin,W.R.W.&Perlmutter,J.S., 1994



Showing articles 850 to 900 of 1691 << Previous Next >>